ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - soybean oil 60 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- valine 6.2 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; fish oil 30 g / 1000 ml; l-histidine 3.0 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l-serine 6.5 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; taurine 1.0 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; olive oil 50 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

cure medical & technical supply - aminoacetic acid; fish oil; glucose monohydrate; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; l-serine; olive oil; soybean oil; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soybean oil 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2.0 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1.0 g / 1000 ml; l-serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; aminoacetic acid 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml - combinations

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride dihydrate; fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- leucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; magnesium sulfate heptahydrate; olive oil; potassium chloride; sodium acetate trihydrate; sodium glycerophosphate hydrated; soya bean oil, refined; taurine; triglycerides, medium-chain; zinc sulfate heptahydrate - תחליב לאינפוזיה - soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; zinc sulfate heptahydrate 0.0178 g / 1000 ml; sodium acetate trihydrate 4.1 g / 1000 ml; potassium chloride 3.48 g / 1000 ml; magnesium sulfate heptahydrate 1.92 g / 1000 ml; sodium glycerophosphate hydrated 3.48 g / 1000 ml; calcium chloride dihydrate 0.574 g / 1000 ml; l- tyrosine 0.4 g / 1000 ml; l- tryptophan 2 g / 1000 ml; taurine 1 g / 1000 ml; l- threonine 4.4 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l- leucine 7.4 g / 1000 ml; l- isoleucine 5.0 g / 1000 ml; l-histidine 3.0 g / 1000 ml; glycine 11.0 g / 1000 ml; l-arginine 12.0 g / 1000 ml; l- alanine 14.0 g / 1000 ml; fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - fish oil; glucose monohydrate; glycine; l- alanine; l- isoleucine; l- lysine acetate; l- methionine; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; l-leucine; olive oil; soya bean oil, refined; taurine; triglycerides, medium-chain - תחליב לאינפוזיה - fish oil 30 g / 1000 ml; olive oil 50 g / 1000 ml; triglycerides, medium-chain 60 g / 1000 ml; soya bean oil, refined 60 g / 1000 ml; glucose monohydrate 462 g / 1000 ml; l- valine 6.2 g / 1000 ml; l- tyrosine 0.40 g / 1000 ml; l- tryptophan 2 g / 1000 ml; l- threonine 4.4 g / 1000 ml; taurine 1 g / 1000 ml; l- serine 6.5 g / 1000 ml; l- proline 11.2 g / 1000 ml; l- phenylalanine 5.1 g / 1000 ml; l- methionine 4.3 g / 1000 ml; l- lysine acetate 9.3 g / 1000 ml; l-leucine 7.4 g / 1000 ml; l- isoleucine 5 g / 1000 ml; l-histidine 3 g / 1000 ml; glycine 11 g / 1000 ml; l-arginine 12 g / 1000 ml; l- alanine 14 g / 1000 ml

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

מדיליין בע"מ - כלל האוכלוסיה - . onychomycosis -טיפול משלים בפטריות בציפורניים, טיפול ב

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - acetyltyrosine 1.23 g/l; arginine 9.2 g/l - solution for infusion - solutions for parenteral nutrition - parenteral nutrition and fluid substitution prophylaxis and therapy of protein deficiency or increased protein needs.

ישראל - עברית - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.